Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Preclinical data presented for sarecycline for the treatment of acne vulgaris

Jan. 11, 2019

Kymab initiates phase II study of KY-1005 in atopic dermatitis

Jan. 9, 2019

Promising phase II data presented for AK-002 in Xolair-naive chronic spontaneous urticaria patients

Jan. 8, 2019

Boehringer Ingelheim patents VNN1 inhibitors

Jan. 3, 2019

Epigenetic protein switches function after development

Jan. 3, 2019

Life Science Institute initiates exploratory clinical trial of CL-2020 in epidermolysis bullosa

Dec. 24, 2018

FDA grants permission to initiate first-in-human study of ASN-008

Dec. 21, 2018

Repigmentation therapy with Scenesse and NB-UVB effective in vitiligo

Dec. 19, 2018

Corbus initiates phase III DETERMINE study based on phase II data in dermatomyositis

Dec. 19, 2018

Pyramid Biosciences licenses TRK modulator from AstraZeneca

Dec. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...